secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001654954-23-007294
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Zivo Bioscience receives Nasdaq delisting notice for $2.5M equity non-compliance
--------------------------------------------------------------------------------

- Nasdaq notified Zivo on May 23, 2023 that it fails to meet $2.5M stockholders' equity requirement (Listing Rule 5550(b)).
- Company plans to request a hearing before Nasdaq Hearings Panel to stay delisting pending compliance plan.
- Previously granted extension to evidence compliance expired May 22, 2023; company was unable to cure.
- No assurance that Panel will grant continued listing or that company can regain compliance within any extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495423007294/0001654954-23-007294-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495423007294/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-007294

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer